person
as of 2026-07-01Robert Findling, MD
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 8
2 publications · 0 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
8
Publications
2 (0 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
1
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
NCT01908192Phase 2, Phase 3Terminated
Publications & congress
1
Diagnosis and Medication Treatment of Schizophrenia in Adolescents.
Drugs · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
PRINCIPAL_INVESTIGATOR